Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucelSaurabh Zanwar, Doris K. Hansen, Oren Pasvolsky et al.|Journal of Hematology & Oncology|2024Cited by 46
Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphomaJennifer L. Crombie, Gary Simmons, Loretta J. Nastoupil et al.|Blood Advances|2021Cited by 36